Evidence map›Paper›PMID 39188299›Full record

ArticleSmart medicine2023

Highly aqueously stable C

Dan Wang, Jianyang Zhao, Roger J Mulder, Julian Ratcliffe, Chunru Wang, Bo Wu, Jinquan Wang, Xiaojuan Hao

Abstract read
In one paragraph

Article in Smart medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Fullerene CInternational journal of molecular sciences · 2024
    Article
  6. Highly aqueously stable CSmart medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dan WangGuangdong Pharmaceutical University Guangzhou Guangdong China.
Jianyang ZhaoManufacturing Commonwealth Scientific and Industrial Research Organisation (CSIRO) Clayton Victoria Australia.
Roger J MulderManufacturing Commonwealth Scientific and Industrial Research Organisation (CSIRO) Clayton Victoria Australia.
Julian RatcliffeManufacturing Commonwealth Scientific and Industrial Research Organisation (CSIRO) Clayton Victoria Australia.
Chunru WangBeijing National Laboratory for Molecular Sciences Institute of Chemistry Chinese Academy of Sciences Beijing China.
Bo WuBeijing National Laboratory for Molecular Sciences Institute of Chemistry Chinese Academy of Sciences Beijing China.
Jinquan WangGuangdong Pharmaceutical University Guangzhou Guangdong China.
Xiaojuan HaoManufacturing Commonwealth Scientific and Industrial Research Organisation (CSIRO) Clayton Victoria Australia.ORCID https://orcid.org/0000-0003-2705-0000

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fullerenes are a class of carbon nanomaterials that find a wide range of applications in biomedical fields, especially for photodynamic cancer therapy because of its photosensitive effect. However, hydrophobic fullerenes can only be dispersed in organic solvents which hinders their biomedical applications. Here, we report a facile method to prepare highly water-dispersible fullerene (C

Indexed as

C60 fullereneC60‐polymer nanoparticlescancer treatmentphotodynamic therapy

Identifiers

PMID39188299
PMCPMC11235996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.